ZEO ScientifiX launches expansion initiative following Florida's new stem cell law

Zeo ScientifiX, Inc.

Florida's SB-1768, effective July 1, 2025, authorizes non-FDA-approved stem cell therapies for defined conditions.
ZEO launched a redesigned website (www.zeoscientifix.com) and partnered with Plus4 PR and Small Circle for brand growth.
CEO Ian Bothwell expects additional states to follow, positioning ZEO to lead with its cGMP-compliant biologics platform.
ZEO aims to set the industry standard via ethically sourced biologics, physician education, and compliant product inventory.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.